Sunnyvale, CA. May 9th, 2012. Clinovo SAS experts will present their latest SAS innovations at the upcoming PharmaSUG annual conference held in San Francisco May 13-May 16, 2012. Clinovo will also be found at Booth #7 where all conference attendees will have a chance to win several prizes.
Sunnyvale, CA. May 2nd, 2012. Clinovo announces that they have reached over 500 downloads of CDISC Express, the first open source SAS®-based system that automatically converts clinical data into CDISC SDTM. Clinovo freely distributes CDISC Express, with user-friendly learning tools and a dedicated support system.
Sunnyvale, CA, April 26, 2012. Clinovo announces that it has successfully attained the status of CDISC® Registered Solutions Provider by the Clinical Data Interchange Standards Consortium (CDISC) organization. With this milestone, Clinovo demonstrates its active participation in the pharmaceutical industry in the implementation of clinical standards.
Sunnyvale, CA, April 22, 2012. Clinovo proves its advanced expertise in open source clinical EDC development by presenting two papers at the annual OpenClinica Global Conference April 22-23, 2012 in Boston, MA.
On March 7th 2012, Clinovo hosted the third Silicon Valley Biotalks, hosted by SNR Denton in their Palo Alto offices. The event welcomed over 60 professionals from the biotechnology and pharmaceuticals industry. The panel was composed of top-tier CDISC experts: John Brega (PharmaStat) CDISC Implementation and eCTD Submissions, Carey Smoak (Roche Molecular) Senior Manager, SAS Programming and CDISC Device Team Leader, Dave Borbas (Jazz Pharmaceuticals) Senior Director, Data Management, and Ale Gicqueau, President & CEO at Clinovo.
Sunnyvale, CA, January 10, 2012 - Clinovo, the leading clinical data solution provider in the San Francisco Bay Area, announced the successful project completion for a fast-growing medical device company’s Phase I clinical trial. Clinovo built the multiple-site study in less than four weeks, meeting the customer’s aggressive deadlines and tight budget. With this milestone, Clinovo demonstrates once again its leading-edge expertise in early phase clinical trials.
Sunnyvale, CA, January 5th, 2012 - Clinovo, the leading clinical data solution provider in the San Francisco Bay Area, announced today the launch of three CDISC Express service packages, adapted to different needs and different budgets. The offer helps pharmaceutical, biotechnology and medical device companies streamline their clinical trials process by using CDSIC SDTM standards.
"Clinovo hosted a truly informative panel discussion on the topic of adaptive clinical trials in Palo Alto,CA on November 2. It was a great forum to hear some very experienced clinical trial professionals share their experiences with a standing-room-only audience. In addition, it was a friendly environment to network with Bay Area colleagues before and after the panel discussion. The event was impressive enough to make me want to embark on my first visit to the blogosphere. Here goes…"
Clinovo's latest white paper "Open Source Technologies for Clinical Trials" was ranked top article in Clinical Leader, the premier online community for clinical research. The article, written by Sophie McCallum, demonstrates how open source technology presents an innovative solution to the challenging pharmaceutical and biotechnology industries, and ultimately helps life science companies bring their medical innovations faster to patients. http://www.clinicalleader.com/
Clinovo features in leading pharmaceutical media with its article that describes how open source technologies can help streamline the clinical trial process. The article demonstrates how open source technology presents an innovative solution to the challenging pharmaceutical and biotechnology industries, and ultimately helps life science companies bring their medical innovations faster to patients. The paper goes over the benefits of open source technologies for the clinical trial process, and describes the major open source clinical data management systems available on the market.
- 1 of 5
- ››
